(Q39714979)

14 September 2017

title

Down-modulation of survivin expression and inhibition of tumor growth in vivo by EZN-3042, a locked nucleic acid antisense oligonucleotide (English)

1 reference

14 September 2017

Puja Sapra

1

1 reference

14 September 2017

Maoliang Wang

2

1 reference

14 September 2017

Raj Bandaru

3

1 reference

14 September 2017

Hong Zhao

4

1 reference

14 September 2017

Lee M Greenberger

5

1 reference

14 September 2017

Ivan D Horak

6

1 reference

14 September 2017

publication date

1 February 2010

1 reference

Nucleosides, Nucleotides & Nucleic Acids

14 September 2017

published in

1 reference

14 September 2017

volume

29

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

97-112

1 reference

Control of apoptosis and mitotic spindle checkpoint by survivin

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Survivin, cancer networks and pathway-directed drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

The molecular basis and potential role of survivin in cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

A p34(cdc2) survival checkpoint in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Survivin mRNA antagonists using locked nucleic acid, potential for molecular cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Pleiotropic cell-division defects and apoptosis induced by interference with survivin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Rational design of shepherdin, a novel anticancer agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

LNA (Locked Nucleic Acids): Synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

SPC3042: a proapoptotic survivin inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Expression of survivin during liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Targeting survivin in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Nuclear interaction of Smac/DIABLO with Survivin at G2/M arrest prompts docetaxel-induced apoptosis in DU145 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Survivin as a therapeutic target for radiation sensitization in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257771003597733

10.1080/15257771003597733

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference